FDA (Drugs) recall action 65690
The FDA (Drugs) publishes a recall like this one as 265 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 265 pages.
Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.
Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug: ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014.
Labeling: Label Mixup: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD60272_16, EXP: 5/22/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 65162066810, Pedigree: AD73646_13, EXP: 5/30/2014.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Aidapak Services, LLC is recalling Niacin TR 750 mg tablets because they may have been mislabeled as Nortriptyline HCL 50 mg capsules.
Aidapak Services, LLC is recalling Pioglitazone HCL 15 mg tablets because they may have been mislabeled as Doxycycline or Lovastatin.
Aidapak Services, LLC is recalling methylprednisolone tablets that may have been mislabeled as levothyroxine, nabumetone, or cholecalciferol.
Aidapak Services is recalling 80 mg Atomoxetine capsules distributed in four states because they may be mislabeled as other medications.
Aidapak Services is recalling Levothyroxine Sodium 175 mcg tablets because they may have been mislabeled as Cinacalcet HCl 60 mg.
Aidapak Services, LLC is recalling Gabapentin 600 mg tablets because they may have been mislabeled as Aripiprazole 15 mg.
Aidapak Services, LLC is recalling 2 mg Nicotine Polacrilex Gum due to a potential labeling mixup with Folic Acid or Quetiapine Fumarate tablets.
Aidapak Services is recalling Nefazodone HCL 150 mg tablets because they may have been mislabeled as Liothyronine Sodium 25 mcg.
Aidapak Services, LLC is recalling Acetaminophen chew tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Isosorbide Dinitrate 10 mg tablets because they may have been mislabeled as Sodium Chloride or Calcitriol.
Aidapak Services is recalling 500 mg sulfasalazine tablets that may be mislabeled as fluconazole or phenytoin sodium.
Aidapak Services is recalling 0.5 mg tacrolimus capsules because they may have been mislabeled as cinacalcet or isosorbide mononitrate.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets due to a potential label mixup with Magnesium Chloride. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Omega-3 Acid Ethyl Esters capsules due to a potential label mixup with other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 500 mg Mycophenolate Mofetil tablets because they may be mislabeled as 250 mg capsules.
Aidapak Services, LLC is recalling Atropine Sulfate/Diphenoxylate HCL tablets because they may have been mislabeled as Cyanocobalamin or Tri-Buffered Aspirin.
Aidapak Services, LLC is recalling 40 mg atorvastatin calcium tablets that may have been mislabeled as 10 mg atorvastatin or 5 mg finasteride.
Aidapak Services is recalling Fluvastatin Sodium 20 mg capsules because they may be mislabeled as Valsartan 80 mg tablets.
Aidapak Services, LLC is recalling 5,000-unit Cholecalciferol tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Disopyramide Phosphate capsules because they may have been mislabeled as Thyroid tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling 250 mg Ascorbic Acid tablets because they may have been mislabeled as other prescription or over-the-counter drugs.
Aidapak Services is recalling Trifluoperazine HCL tablets because they may have been mislabeled as Terbutaline Sulfate.
Aidapak Services is recalling Liothyronine Sodium 25 mcg tablets because they may have been mislabeled as Levothyroxine Sodium or Hyoscyamine Sulfate.
Aidapak Services, LLC is recalling 50 mg Mercaptopurine tablets because they may have been mislabeled as 500 mg Ascorbic Acid tablets.
Aidapak Services is recalling Fluconazole 200 mg tablets because they may have been mislabeled as Valsartan or Fluconazole 100 mg.